Skip to main content
Premium Trial:

Request an Annual Quote

New York, Florida, and California License Genomas Laboratory

NEW YORK (GenomeWeb News) – Pharmacogenomics firm Genomas today announced it has obtained clinical laboratory licenses from New York, Florida, and California.

The company's Laboratory of Personalized Health received CLIA certification in 2005, the same year the lab received licensure from Connecticut.

Last year, Genomas was credentialed as a Medicare provider and began providing services in Texas and Pennsylvania.

"New York, Florida, and California are among the most demanding states in terms of laboratory technical expertise and business credentialing," Gualberto Ruano, president of Genomas and director of the Laboratory of Personalized Health, said in a statement. "Now we are determined to bring our clinical pharmacogenetics services to the people of these states and the entire nation."

In 2005 Genomas launched it HILOmet PhyzioType system and inked a distribution agreement with Clinical Laboratory Partners. Today Genomas, based in Hartford, Conn., said that more than 500 clinicians and 5,000 patients had benefitted from the test, which enables personalized management of more than 250 drugs targeted at mental illness, pain, diabetes, and heart disease.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.